Home      Tickers | SPY | NQ100 | DOW | Global | ETFs | Sector ETFs | 3x ETFs | ETF Movers | Stock Movers | Trading Alerts
     ^  DVAX:  Intraday  Hourly  Forecast  Similar  Waves  GapOpen  Research  Timing  Gains  Losses  Strategies  Practice
     Wed. Nov. 18, 2020

Trading Signals: DVAX Stock Price Prediction and Forecast (Thu. Feb. 19, 2004 - Fri. Dec. 22, 2023)

(Dynavax Technologies Corporation)

Market is closed on Wed. Nov. 18, 2020


Trend Analysis and Forecast
 
Average Daily Percentage Swing  0% (three month average)
RSI   
Latest Price   $(0%)
Stocks Behave Similarly  Similar Stock List
Market Behavior  Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs  Broad market will support DVAX advance at 0% a week (0% probability)
  LIT(10%)    XBI(8%)    IBB(7%)    TAN(7%)    ARKG(6%)  
Factors Impacting DVAX price  DVAX will advance at least -0% in a week (0% probabilities).
  XLE(-6%)    GDXJ(-6%)    GDX(-6%)    SIL(-5%)    GLD(-5%)  
 
 
Relative Volatility  
 
Market Trend Strength  0% (StdDev 0%)
Hourly BBV   0.2 ()
Intraday Trend   NAN%
  
 

  

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

July 7, 2020 DVAX is developing a vaccine candidate SCB-2019 with GlaxoSmithKline plc GSK which is in its phase 1 clinical trials. The vaccine is made up of S-Trimer protein that resembles the coronavirus spike protein and hence triggers the immune system to produce antibodies.

$. DVAX price fluctuates within NAN% (three month std-dev: 0%) daily (68% of days).

getNextHourMoveProbability failed